LA JOLLA PHARMACEUTICAL CO Insider Trading for April 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for April 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 6.60 | 58 | 383 | 58 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 5.61 | 58 | 325 | 4,876 | 4.8 K to 4.9 K (+1.20 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 6.60 | 34 | 224 | 34 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 5.61 | 34 | 191 | 9,504 | 9.5 K to 9.5 K (+0.36 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 6.60 | 350 | 2,310 | 350 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 5.61 | 350 | 1,964 | 8,797 | 8.4 K to 8.8 K (+4.14 %) |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 6.60 | 146 | 964 | 146 | |
| Apr 17 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 5.61 | 146 | 819 | 81,293 | 81.1 K to 81.3 K (+0.18 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 4.20 | 165 | 693 | 165 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 3.57 | 165 | 589 | 8,447 | 8.3 K to 8.4 K (+1.99 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Option Exercise | A | 4.20 | 459 | 1,928 | 459 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Wellinghoff Darryl | Chief Commercial Of ... | Grant | A | 3.57 | 459 | 1,639 | 9,470 | 9 K to 9.5 K (+5.09 %) |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 4.20 | 229 | 962 | 229 | |
| Apr 02 2020 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 3.57 | 229 | 818 | 81,147 | 80.9 K to 81.1 K (+0.28 %) |